Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-28

Clinical Trial Update: Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing carbetocin to oxytocin for preventing postpartum hemorrhage during emergency cesarean delivery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Al-Kindy College of Medicine | Conditions: Postpartum Hemorrhage (Primary) | Phase 4 | Status: COMPLETED